Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial
Go back to Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial| Edwards Lifesciences (NYSE: EW) | Delayed: 85.49 -1.28 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.77 | 52 Week High | $166.87 | |||
| Open | $87.51 | 52 Week Low | $72.20 | |||
| Day High | $87.76 | P/E | 24.85 | |||
| Day Low | $85.26 | EPS | $3.44 | |||
| Volume | 581,730 | |||||
